Scores by kind of claim
Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.
-
Factual claims
Statements about the present or the past, checked against the record: did they hold up?
80 72 88 -
Predictions
Statements about events outside the person's control, checked once they fell due: did they come true?
70 62 78 -
Promises
Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?
Insufficient record: 2 promises resolved, 5 needed for a score.
All types combined: 75 (likely 69 to 80, high confidence), from 79 claims: 35 factual claims, 44 predictions. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.
Scott Alexander's claims
39 claims
“We definitely have the technology to do the polygenic score thing.”
Scott Alexander, blogger 20 February 2023 Grading My 2018 Predictions For 2023 (Astral Codex Ten)
As of 2023 the technology to offer polygenic scores to consumers definitely exists.
Resolved true The record shows it happened or was so.
What would count as true or false
This is judged as of February 2023. TRUE if by then the technology to compute and deliver polygenic scores to individuals existed and was in use, for example commercial services offering polygenic risk scores or polygenic embryo screening to paying customers, or validated published methods able to do so. MOSTLY TRUE if the technology existed but was offered only in limited or clinical settings rather than directly to consumers. MOSTLY FALSE if only research-stage methods existed and none had been deployed. FALSE if polygenic scoring could not be done at all as of 2023.
Evidence
- Consumer genetic testing: expectation and reality - Genomics Education Programme Genomics Education Programme (NHS) · 15 January 2020
“Polygenic risk scores offer a way to quantify the risk for some diseases, and many DTC tests now report them; but their predictive power should not be overestimated.”
- Consumer genetic testing: expectation and reality - Genomics Education Programme Genomics Education Programme (NHS) · 15 January 2020
“Professor Lucassen explains in the podcast that the value of polygenic risk scores is currently limited to a public health setting – stratifying patients according to risk and treating them accordingly – rather than for individuals.”
Reasoning
E1 is a 2020 NHS Genomics Education Programme article, independent of the subject. It says polygenic risk scores "offer a way to quantify the risk for some diseases, and many DTC tests now report them." That means consumer services were already computing polygenic scores and giving them to individuals well before February 2023, which meets the TRUE criterion. E2 questions how useful these scores are for individuals, but it does not dispute that the technology existed and was being used.
Cite this claim
Scott Alexander, “As of 2023 the technology to offer polygenic scores to consumers definitely exists.” (said 20 February 2023). Verdict: resolved true. Reliability API, claim c_0a3032035d51, method 0.1.0+8bea457b. https://epistacklabs.com/claims/c_0a3032035d51
Claims without a verdict
Is a verdict here wrong, or do you speak for Scott Alexander? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.